Getinge announced today that it has acquired Healthmark Industries, a Fraser, Michigan–based provider of instrument care and infection control consumables.
The Swedish medtech company paid $320 million in cash for 100% of Healthmark.
The acquisition aims to bolster Getinge’s footprint in the U.S. sterile reprocessing market while paving the way for Healthmark’s global expansion. The field is more important than ever: In the U.S. alone, there are more than 2.8 million antimicrobial-resistant infections and 35,000 resulting deaths annually, according to the CDC.
“Together, we will offer a broad range of solutions to sterile processing departments in hospitals,” Stéphane Le Roy, president Surgical Workflows at Getinge, said in a news release.
“Healthmark’s position in the field of consumables for cleaning verification and packaging will be an ideal complement to our consumables, reprocessing capital equipment, and software solutions. The acquisition strengthens Getinge’s position in the infection prevention sector in the US, and our global customer reach in Europe and Asia will also accelerate Healthmark’s international development.”
Established in 1969, Healthmark operates its main production out of Fraser, with an additional facility in Bobigny, France. The company has a global workforce of around 400. Projected net sales for Healthmark by the end of its fiscal year ended Oct. 31, 2023, are near $126 million, marking an estimated 15% increase from 2022. These figures are expected to significantly enhance the net revenue and EBITDA of Getinge’s Surgical Workflows division. Notably, the U.S. market contributes to approximately 90% of Healthmark’s sales.
Mark Basile, Healthmark’s President and CEO, expressed optimism about the merger, highlighting the complementary nature of both companies’ product portfolios. Basile said in the news release: “This combination makes sense due to the minimal overlap in our product portfolios. By bringing together our strengths, we are well positioned to better serve our customers, gain greater control over our supply chain and finished products, and expand our reach outside the United States.”
